Connectus Wealth’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$9.51M Buy
105,461
+17,814
+20% +$1.51M 0.26% 87
2023
Q4
$7M Buy
87,647
+6,306
+8% +$474K 0.14% 144
2023
Q3
$5.78M Buy
81,341
+65,603
+417% +$4.91M 0.13% 148
2023
Q2
$1.21M Buy
15,738
+2,191
+16% +$170K 0.03% 266
2023
Q1
$1.02M Sell
13,547
-2,599
-16% -$193K 0.03% 283
2022
Q4
$1.27M Buy
16,146
+2,464
+18% +$185K 0.03% 261
2022
Q3
$961K Sell
13,682
-2,278
-14% -$179K 0.02% 342
2022
Q2
$1.28M Buy
15,960
+3,477
+28% +$272K 0.03% 242
2022
Q1
$1.06M Sell
12,483
-3,091
-20% -$245K 0.03% 236
2021
Q4
$1.33M Buy
+15,574
New +$1.22M 0.05% 181

Other funds holding CL

Connectus Wealth's CL Position: Q1 2024 in Review

Connectus Wealth increased its Colgate-Palmolive (CL) stake by 20% in Q1 2024, buying an estimated $1.51M and bringing the position to 105,461 shares worth $9.51M. The position accounts for 0.26% of the portfolio, ranked #87.

Connectus Wealth first reported a position in CL in Q4 2021 and has held it in 10 quarters since. 1,765 funds tracked by Wall St. Rank hold CL as of Q1 2024.

  • Connectus Wealth held 105,461 shares of Colgate-Palmolive worth $9.51M as of Q1 2024.
  • Connectus Wealth bought 17,814 Colgate-Palmolive shares in Q1 2024, an estimated $1.51M.
  • Colgate-Palmolive made up 0.26% of Connectus Wealth's portfolio in Q1 2024, its #87 holding.
  • Connectus Wealth first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 10 quarters since.
  • 1,765 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.